Stock Events

Quest Diagnostics 

$140.45
167
-$0.45-0.32% Friday 20:00

Statistics

Day High
142
Day Low
138.77
52W High
145.62
52W Low
117.6
Volume
1,017,592
Avg. Volume
762,607
Mkt Cap
15.6B
P/E Ratio
18.8
Dividend Yield
2.14%
Dividend
3

Upcoming

Dividends

2.14%Dividend Yield
10Y Growth
8.66%
5Y Growth
6.9%
3Y Growth
6.94%
1Y Growth
6.09%

Earnings

23JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
1.86
2.02
2.17
2.33
Expected EPS
2.33
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DGX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap0
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap7.84B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap211.09B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap185.06B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap37.82B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap3.53B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Exact Sciences
EXAS
Mkt Cap7.8B
Exact Sciences Corporation is known for its non-invasive screening test for colorectal cancer, competing in the diagnostics market.
Neogenomics
NEO
Mkt Cap1.77B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap2.21B
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

Analyst Ratings

148.67$Average Price Target
The highest estimate is $155.
From 9 ratings within the last 6 months. This is not an investment recommendation.
Buy
22%
Hold
78%
Sell
0%

About

Health Services
Services to the Health Industry
Manufacturing
Dental Laboratories
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Show more...
CEO
Stephen Rusckowski
Employees
50000
Country
US
ISIN
US74834L1008
WKN
000904533

Listings